Search for: "Impax Laboratories, Inc"
Results 41 - 60
of 78
Sorted by Relevance
|
Sort by Date
16 Oct 2006, 7:58 pm
Source: Impax press release. [read post]
24 Nov 2010, 12:37 am
(Orange Book Blog) (Patent Docs) Welchol (Colesevelam) – US: Impax confirms patent challenge relating to Welchol for oral suspension (SmartBrief) [read post]
5 May 2010, 4:46 am
Impax Laboratories Inc. [read post]
27 Jul 2011, 4:06 pm
The court granted leave to file briefs amici curiae to Teva Pharmaceuticals, USA, Inc., Mylan Pharmaceuticals Inc., Apotex Inc. and Impax Laborato- ries, Inc., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en banc, the response to the petition, and… [read post]
24 Mar 2010, 4:45 am
Impax Laboratories, Inc. [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
18 Mar 2010, 2:30 am
Paddock Laboratories, Inc. [read post]
10 Feb 2011, 5:35 pm
Karst – Late last year, Impax Laboratories, Inc. [read post]
10 Jun 2010, 3:58 am
Paddock Laboratories, Inc. [read post]
10 Feb 2010, 4:47 pm
Impax Laboratories Inc. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor… [read post]
16 Jun 2010, 3:02 pm
Paddock Laboratories Inc. [read post]
22 Feb 2017, 7:44 am
The FTC also announced that, in a related matter, it had filed an administrative complaint targeting a similar reverse-payment agreement to delay entry of a generic medication with California-based drugmaker Impax Laboratories (NASDAQ:IPXL). [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
24 Jul 2009, 2:29 pm
Impax Laboratories, Inc., 248 F.R.D. 169 (Oct. 26, 2006), declining to order a native production. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
20 Nov 2007, 12:12 pm
Impax Laboratories, Inc., 2006 WL 3091331, *2 (D. [read post]
27 Aug 2009, 7:43 am
Impax Labs., Inc. v. [read post]
11 May 2010, 4:00 pm
IMPAX Laboratories, Inc. [read post]
29 Jul 2010, 10:24 am
’s (“Caraco”) and Sun Pharmaceutical Laboratories, Ltd. [read post]
